Association between Brown Adipose Tissue and metabolic health in patients with manifest vascular disease or at high risk for cardiovascular events.

Association between Brown Adipose Tissue and metabolic health in patients with manifest vascular disease or at high risk for cardiovascular events. - Imaging brown adipose tissue with MRI.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41498

Enrollment

Registered

2014-01-20

Start date

2014-04-16

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vetweefsel brown adipose tissue

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients participating in the SMART cohort (protocol number 96-048).

Exclusion criteria

Exclusion criteria: - Pregnancy or lactation. - Mentally incapacitated subjects. - Claustrophobia. - Waist circumference >200cm. - Metallic devices in the body of the participant such as cardioverter-defibrillators (AICD/ICD), pacemakers, cochlear implants, implanted insulin pumps, endoscopic (gastric) or aneurysm (brain) clips according to the UMCU MRI guidelines. (https://richtlijn.mijnumc.nl/Beeld/MRI/Documents/MRI%20Veiligheid%20MRI%20contra-indicaties.pdf) - Patients with HIV infection.

Design outcomes

Primary

Measure	Time frame
Reproducibility of measuring BAT volume (mL) within the supraclavicular fossae by determining inter-scan, inter-observer and intra-observer variability. Addendum. Adipose tissue estimated Fat Fraction. From this a volume estimation of brown adipose tissue can be derived.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results